PHENYLKETONE CARBOXYLATE COMPOUNDS OF FORMULA I, WHEREIN N=2-6； R=C(0)； -OC(O)- OR - CH( OH)-； A IS (CH2)mCOOH, W(CH2)mCOOH OR YCH(COOH)((CH2)pCH3) WHEN B IS FT； B IS (CH2)mCOOH, W(CH2)mCOOH OR YCH(COOH)((CH2)pCH3) WHEN A IS FT OR A AND B FORM A 5-7 MEMBERED CYCLOALKYL SUBSTITUTED WITH COOFt W=0, S OR NFt Y=0, S, NH OR CH2； m=0-2； p=1-7； HAVE BEEN PREPARED. THESE COMPOUNDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS HAVE BENEFICIAL THERAPEUTIC EFFECTS TO PREVENT OR TREAT A CONDITION RELATED TO (I) BLOOD DISORDERS, (II) INFLAMMATION RELATED DISEASES, (III) RENAL DISORDERS AND/OR RENAL DISORDERS COMPLICATIONS, OR (IV) FIBROSIS-RELATED ORGAN DYSFUNCTION.
